S&P 500

5.277,51

0,80%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Oncology Institute Inc (TOI)
Oncology Institute Inc (TOI) Notícias

TOI

Oncology Institute (TOI)

Oncology Institute Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:TOI

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
29/05/2024	09:00	GlobeNewswire Inc.	The Oncology Institute to Participate at Upcoming Investor Conferences	NASDAQ:TOI	Oncology Institute Inc
22/05/2024	09:00	GlobeNewswire Inc.	The Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring Conference	NASDAQ:TOI	Oncology Institute Inc
14/05/2024	17:05	GlobeNewswire Inc.	The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance	NASDAQ:TOI	Oncology Institute Inc
07/05/2024	17:05	GlobeNewswire Inc.	The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit	NASDAQ:TOI	Oncology Institute Inc
23/04/2024	09:00	GlobeNewswire Inc.	The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
08/04/2024	09:00	GlobeNewswire Inc.	Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute	NASDAQ:TOI	Oncology Institute Inc
04/04/2024	09:00	GlobeNewswire Inc.	The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California	NASDAQ:TOI	Oncology Institute Inc
27/03/2024	17:05	GlobeNewswire Inc.	The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024	NASDAQ:TOI	Oncology Institute Inc
14/03/2024	09:09	GlobeNewswire Inc.	MaxHealth & The Oncology Institute Expand Value-Based Care Partnership	NASDAQ:TOI	Oncology Institute Inc
06/03/2024	10:00	GlobeNewswire Inc.	The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
20/02/2024	10:00	GlobeNewswire Inc.	Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model	NASDAQ:TOI	Oncology Institute Inc
25/01/2024	10:00	GlobeNewswire Inc.	WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio	NASDAQ:TOI	Oncology Institute Inc
19/01/2024	18:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TOI	Oncology Institute Inc
28/12/2023	19:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
04/12/2023	10:00	GlobeNewswire Inc.	The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California	NASDAQ:TOI	Oncology Institute Inc
08/11/2023	18:43	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TOI	Oncology Institute Inc
08/11/2023	18:41	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TOI	Oncology Institute Inc
08/11/2023	18:05	GlobeNewswire Inc.	The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance	NASDAQ:TOI	Oncology Institute Inc
18/10/2023	09:03	GlobeNewswire Inc.	The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
11/10/2023	17:05	GlobeNewswire Inc.	The Oncology Institute Names Jeremy Castle as Chief Operations Officer	NASDAQ:TOI	Oncology Institute Inc
26/09/2023	17:05	GlobeNewswire Inc.	The Oncology Institute Executive Leaders to Present at the 2023 Association for Value-Based Cancer Care (AVBCC) Summit	NASDAQ:TOI	Oncology Institute Inc
18/09/2023	09:00	GlobeNewswire Inc.	The Oncology Institute Regains Compliance with Nasdaq Listing Requirements	NASDAQ:TOI	Oncology Institute Inc
07/09/2023	15:36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:TOI	Oncology Institute Inc
09/08/2023	09:10	GlobeNewswire Inc.	Ambience Healthcare and The Oncology Institute (TOI) Partner to Create a Best-in-Class Oncology Experience for Patients and Clinicians, Leveraging Breakthrough Generative AI Technology	NASDAQ:TOI	Oncology Institute Inc
08/08/2023	17:40	GlobeNewswire Inc.	The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance	NASDAQ:TOI	Oncology Institute Inc
31/07/2023	09:00	GlobeNewswire Inc.	The Oncology Institute Partners with House Rx to Accelerate Growth of Pharmacy Operations	NASDAQ:TOI	Oncology Institute Inc
18/07/2023	09:00	GlobeNewswire Inc.	The Oncology Institute Announces Second Quarter 2023 Earnings Release Date and Conference Call	NASDAQ:TOI	Oncology Institute Inc
20/06/2023	07:00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:TOI	Oncology Institute Inc
14/06/2023	18:29	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:TOI	Oncology Institute Inc
14/06/2023	18:23	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:TOI	Oncology Institute Inc